| Model 1 R 2=.05 | Model 2 R 2=.18 | Model 3 R 2=.26 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | b | SEMb | β | t | b | SEMb | β | t | b | SEMb | β | t |
Age | -.16 | .04 | -.17 | -.3.63** | -.15 | .04 | -.16 | -3.51** | -.15 | .04 | -.16 | -3.81** |
Body Mass Index | -.13 | .09 | -.09 | 1.52** | -.04 | .08 | -.03 | -.50 | -.03 | .08 | -.02 | -.41 |
Gender | −2.43 | 1.19 | -.10 | -2.04* | -- | -- | -- | -- | -- | -- | -- | -- |
Physical Function (Phase 1) | Â | .37 | .07 | -.25 | 5.17** | .35 | .07 | .24 | 5.34** | |||
Approach Coping | Â | -.27 | .13 | -.10 | -2.07* | -- | -- | -- | -- | |||
Physical Symptoms (Phase 1) | Â | -.28 | .09 | -.14 | -3.13** | -- | -- | -- | -- | |||
Smoking | Â | .61 | .78 | .04 | .79 | .35 | .66 | .02 | .52 | |||
Systolic Blood Pressure reactivity after a stressor | Â | .14 | .05 | .15 | 3.13** | .11 | .04 | .12 | 2.58* | |||
Physical Symptoms (Phase 2) | Â | Â | .38 | .06 | -.24 | -5.79** | ||||||
Injury | Â | Â | -2.46 | .98 | -.16 | -2.50* |